Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product
Go back to Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product| Philip Morris International, Inc. (NYSE: PM) | Delayed: 174.19 -4.21 (2.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $178.40 | 52 Week High | $104.20 | |||
| Open | $178.05 | 52 Week Low | $83.33 | |||
| Day High | $178.89 | P/E | 32.93 | |||
| Day Low | $174.03 | EPS | $5.29 | |||
| Volume | 1,846,768 | |||||
| PMI Group, Inc. (NYSE: PMI) | Delayed: 0.17 -0.01 (5.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.18 | 52 Week High | $4.14 | |||
| Open | $0.18 | 52 Week Low | $0.15 | |||
| Day High | $0.18 | P/E | N/A | |||
| Day Low | $0.17 | EPS | $-5.35 | |||
| Volume | 1,973,819 | |||||
